Biological markers and diagnosis of ventilator-associated pneumonia

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Fagon, Jean Yves ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLARA CELL PROTEIN; CORTICOSTEROID; ELASTIN; ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR; PROCALCITONIN; SURFACTANT PROTEIN D; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UTEROGLOBIN;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EXPOSURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; NOTE; PRIORITY JOURNAL; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; CHEMISTRY; FEMALE; INTENSIVE CARE; MALE; METHODOLOGY;

BRONCHOALVEOLAR LAVAGE FLUID; CRITICAL CARE; FEMALE; HUMANS; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; UTEROGLOBIN;

EID: 84858808851     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10050     Document Type: Note

References (21)

1. Vanspauwen MJ, Bruggeman CA, Jacobs JA, Drent M, Bergmans DCJJ, van Mook WNKA. Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia?. Crit Care 2011, 15:R14. 10.1186/cc9418, 21223571.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
3. Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K, Sakr Y. Diag-nosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 2008, 12:R56. 2447611, 18426596, 10.1186/cc6877.
4. Morrow LE, Kollef MH. Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med 2010, 38(8 Suppl):S352-362. 10.1097/CCM.0b013e3181e6cc98, 20647793.
5. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J, . EU-VAP/CAP Study Group Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009, 37:2360-2368. 10.1097/CCM.0b013e3181a037ac, 19531951, EU-VAP/CAP Study Group.
6. Spellberg B, Talbot G. Infectious Diseases Society of America (IDSA); American College of Chest Physicians (ACCP); American Thoracic Society (ATS); Society of Critical Care Medicine (SCCM) Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010, 51(Suppl 1):S150-170. 2947853, 20597666, Infectious Diseases Society of America (IDSA); American College of Chest Physicians (ACCP); American Thoracic Society (ATS); Society of Critical Care Medicine (SCCM).
7. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268. 10.1378/chest.122.1.262, 12114368.
8. Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA, . the Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011, the Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators.
9. Johnston P, McAuley DF, O'Kane CM. Novel pulmonary biomarkers in the diagnosis of VAP. Thorax 2010, 65:190-192. 10.1136/thx.2009.127308, 20335284.
10. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering recep-tor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350:451-458. 10.1056/NEJMoa031544, 14749453.
11. Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008, 34:1434-1440. 10.1007/s00134-008-1112-x, 18421435.
12. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008, 12:R11. 2374597, 18252006, 10.1186/cc6780.
13. Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008, 45:293-298. 10.1258/acb.2007.007133, 18482918.
14. Conway Morris A, Kefala K, Wilkinson TS, Moncayo-Nieto OL, Dhaliwal K, Farrell L, Walsh TS, Mackenzie SJ, Swann DG, Andrews PJ, Anderson N, Govan JR, Laurenson IF, Reid H, Davidson DJ, Haslett C, Sallenave JM, Simpson AJ. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 2010, 65:201-207. 2866736, 19825784, 10.1136/thx.2009.122291.
15. Srinivasan R, Song Y, Wiener-Kronish J, Flori HR. Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Pediatr Crit Care Med 2011, 12:21-27. 10.1097/PCC.0b013e3181e2a352, 20473240.
16. Determann RM, Millo JL, Waddy S, Lutter R, Garrard CS, Schultz MJ. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study. BMC Pulm Med 2009, 9:49. 2794841, 19958527, 10.1186/1471-2466-9-49.
17. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Prognostic val-ue of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Intensive Care Med 2008, 34:2084-2091. 10.1007/s00134-008-1173-x, 18523752.
18. Flanagan PG, Jackson SK, Findlay G. Diagnosis of gram negative, ventilator asso-ciated pneumonia by assaying endotoxin in bronchial lavage fluid. J Clin Pathol 2001, 54:107-110. 1731359, 11215277, 10.1136/jcp.54.2.107.
19. el-Ebiary M, Torres A, González J, Martos A, Puig de la Bellacasa J, Ferrer M, Rodriguez-Roisin R. Use of elastin fibre detection in the diagnosis of ventilator associated pneumonia. Thorax 1995, 50:14-17. 473697, 7886642, 10.1136/thx.50.1.14.
20. Anand NJ, Zuick S, Klesney-Tait J, Kollef MH. Diagnostic implications of soluble trig-gering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135:641-647. 10.1378/chest.08-1829, 18849395.
21. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, . PRORATA trial group Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474. 10.1016/S0140-6736(09)61879-1, 20097417, PRORATA trial group.